Related Experiment Video

Updated: Mar 29, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

1.3K

Severe Respiratory Distress in a Child with Pulmonary Idiopathic Hemosiderosis Initially Presenting with

A Potalivo1, L Finessi1, F Facondini1

  • 1Department of Emergency, Anaesthesia and Intensive Care Section, Infermi Hospital, Viale Luigi Settembrini 2, 47923 Rimini, Italy.

Case Reports in Pulmonology
|December 4, 2015
PubMed

Insights

Idiopathic pulmonary hemosiderosis (IPH) is a rare lung condition causing anemia and respiratory issues in children. Early recognition and corticosteroid treatment can lead to rapid improvement.

Area of Science:

  • Pediatric Pulmonology
  • Rare Diseases
  • Hematology

Background:

  • Idiopathic pulmonary hemosiderosis (IPH) is a rare cause of alveolar hemorrhage in children.
  • It presents with recurrent hemoptysis, lung infiltrates, and iron-deficiency anemia.
  • Diagnosis can be challenging due to unclear pathogenesis and variable clinical presentation.

Purpose of the Study:

  • To highlight the importance of considering IPH in pediatric patients with unexplained anemia and respiratory symptoms.
  • To present a case study illustrating the diagnostic and therapeutic approach to IPH.
  • To emphasize the effectiveness of immunosuppressive therapy in managing IPH.

Main Methods:

  • Case report of a 6-year-old boy with severe iron-deficiency anemia, acute respiratory failure, and hemoptysis.
  • Diagnostic suspicion of IPH based on clinical presentation.
  • Treatment initiated with high-dose corticosteroids as immunosuppressive therapy.

Main Results:

  • The patient experienced rapid clinical improvement following the initiation of corticosteroid therapy.
  • Successful management of severe acute respiratory failure and hemoptysis.
  • Discharge from the hospital in improved condition.

Conclusions:

  • IPH should be considered in the differential diagnosis of pediatric anemia with respiratory complications.
  • Prompt diagnosis and initiation of immunosuppressive therapy, particularly corticosteroids, can lead to favorable outcomes.
  • This case underscores the potential for effective management of IPH in children.

More Related Videos

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

2.2K
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.1K

Related Concept Videos

Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
709
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.5K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.1K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
633
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
4.8K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.5K